Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Alnylam Pharmaceuticals is a biopharmaceutical company that specializes in RNA interference (RNAi) therapeutics, aiming to silence genes that contribute to diseases. Their mission is to develop innovative medicines that can transform the lives of patients suffering from various conditions.
Claim this profile to keep your information accurate and add what's missing.
Not in this profile yet:
An innovative class of medicines that treat diseases by silencing the genes responsible for them.
RNA interference (RNAi) is a naturally occurring process that regulates gene expression by silencing specific genes to prevent the production of disease-causing proteins.
Alnylam's RNAi therapeutics focus on both rare and prevalent diseases across several therapeutic areas.
Patients are at the center of Alnylam's mission, inspiring the company to innovate and develop treatments that improve their quality of life.